AZ says Brilinta hits the mark in diabetic heart disease - PMLiVE

AZ says Brilinta hits the mark in diabetic heart disease  PMLiVE

AstraZeneca has chalked up another clinical trial win for its antiplatelet drug Brilinta, showing that it can reduce cardiovascular events in diabetics with coronary ...